DoD extends DIN-PACS contract with InformaTech

Article

DoD extends DIN-PACS contract with InformaTechInformaTech, a provider of medical and information technology services, recently secured an extension of an existing telemedicine project and a new telemedicine contract. The company’s technical

DoD extends DIN-PACS contract with InformaTech

InformaTech, a provider of medical and information technology services, recently secured an extension of an existing telemedicine project and a new telemedicine contract. The company’s technical support contract with the Defense Supply Center Philadelphia for management of the DIN-PACS project has been extended for an indefinite period of time; in addition, InformaTech was awarded a new contract by the U.S. Navy to provide acceptance testing services for the IBM PACS recently installed at the Naval Medical Center in Norfolk, VA. The Medical Services division of InformaTech, which is a wholly owned subsidiary of Dallas-based Kaneb Services, provides systems integration and open-architecture telemedicine products and services.

© 2000 Miller Freeman, Inc., a United News & Media company.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.